Cover

Cover Page

Research Article

Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection

• Şua SÜMER
• Onur URAL
• Nazlım AKTUĞDEMİR
• Gaye URAL
• Mehmet BALCI
• Nebahat DİKİCİ

Evaluation of Non-invasive Methods for Prediction of Fibrosis in Chronic Hepatitis B and CInfections

• Onur KAYA
• Füsun Zeynep AKÇAM
• Yonca SÖNMEZ
• Arzu TIĞLI
• Metin ÇİRİŞ

Is a Booster Dose of Primary Vaccinationagainst Hepatitis B Necessary After Five Years?

• Selma TOSUN
• Selahattin AKSU

Seroprevalence of Hepatitis Delta Virus in Afyonkarahisar

• Tuna DEMİRDAL
• Neşe DEMİRTÜRK
• Zerrin AŞÇI

Knowledge Levels About Hepatitis and Risk Perception in the Relatives of Hepatitis B and C Patients

• Serpil POYRAZOĞLU
• Zeynep BAYKAN
• Melis NAÇAR
• Fevziye ÇETİNKAYA

Case Report

Pegylated Interferon Alpha 2a Associated Dermatitis: A Case Report

• Saygın NAYMAN ALPAT
• Salih Atakan NEMLİ
• Nurettin ERBEN
• Elif DOYUK KARTAL
• İlhan ÖZGÜNEŞ
• Gaye USLUER